En

April 28 - May 1, 2019Oegstgeest (near Leiden), The Netherlands

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants is limited to 35, to allow in depth discussion. Should the number of applications exceed the maximum, preference will be given to applicants from EFMC adhering countries and employees of EFMC corporate members. Upon special request to the organisers, only based on financial conditions and supported by an argued recommendation of the head of the department of the applicant, up to 3 applicants from academia may be admitted at a reduced fee.

Confirmed Speakers:

  • Dr Xavier BARRIL (GAIN THERAPEUTICS, Mataro)
  • Dr Ben DAVIS (VERNALIS PLC, Cambridge, United Kingdom)
  • Dr Paul ENGLAND (IOTA PHARMACEUTICALS LTD., Cambridge, United Kingdom)
  • Dr Mike HANN (GLAXOSMITHKLINE, Stevenage, United Kingdom)
  • Prof. Rod HUBBARD (UNIVERSITY OF YORK & VERNALIS, Cambridge, United Kingdom)
  • Prof. Gyorgy KESERU (RESEARCH CENTRE FOR NATURAL SCIENCES, HUNGARIAN ACADEMY OF SCIENCES, Budapest, Hungary)

Organised by: Iwan DE ESCH (VU University Amsterdam, The Netherlands) and Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Organised by:
  • European Federation of Medecinal Chemistry (EFMC)